Our Pricing

Weight Loss Injections in Stoke-on-Trent: Expert Guide to Mounjaro, Wegovy & Saxenda

Published: 29 September 2026

Residents seeking weight loss injections Stoke on Trent now have convenient access to clinically proven GLP-1 treatments through UK-registered online pharmacies. Our GPhC-registered service (9012511) connects Stoke-on-Trent patients with licensed prescribers for Mounjaro, Wegovy, and Saxenda, delivering genuine medicines discreetly to your door with free consultations completed in under 3 minutes.

What Are Weight Loss Injections Available in Stoke-on-Trent?

Weight loss injections Stoke on Trent residents can access include three MHRA-licensed GLP-1 receptor agonists: tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda). These prescription medicines work by mimicking natural gut hormones that regulate appetite and blood sugar, helping patients achieve clinically significant weight reduction when combined with lifestyle modifications [1].

Mounjaro represents the latest advancement, targeting both GLP-1 and GIP receptors for dual-action metabolic control. Clinical trials demonstrated average weight loss of 15-22.5% of body weight over 72 weeks, depending on dose [1]. Wegovy, a once-weekly semaglutide injection, showed average reductions of 15% body weight in the STEP trials [2]. Saxenda, a daily liraglutide injection, typically produces 5-10% weight loss over 56 weeks [3].

All three treatments require prescription approval following clinical assessment by a UK-registered prescriber. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every patient receives pharmaceutical care tailored to their medical history, current medications, and weight loss goals.

How to Access Weight Loss Injections Stoke on Trent Online

Accessing weight loss injections Stoke on Trent through Cured Pharmacy involves a streamlined three-step process designed for convenience without compromising clinical safety. First, complete our free online consultation form, which takes under 3 minutes and covers your medical history, current health conditions, medications, and weight management goals.

Our UK-registered prescribers review your assessment within hours, not days. If clinically appropriate, they issue an NHS-standard prescription and select the optimal treatment from Mounjaro, Wegovy, or Saxenda based on your individual profile. You receive transparent pricing before any payment commitment—Mounjaro from £124.99, Wegovy from £124.99, Saxenda from £124.99.

Once approved, your prescription is dispensed by our GPhC-registered pharmacy and dispatched via Royal Mail in 100% discreet packaging. Most Stoke-on-Trent addresses receive delivery within 1-2 working days. Our clinical team remains available throughout your treatment journey for dosage adjustments, side effect management, and ongoing support.

Same-Day Prescription Approval for Stoke-on-Trent Patients

Unlike traditional GP appointments requiring weeks of waiting, our digital consultation system prioritises rapid access to weight loss injections Stoke on Trent residents need. Prescribers typically review assessments within 2-4 hours during business days, with most patients receiving approval the same day they apply. This efficiency doesn't compromise safety—every application undergoes the same rigorous clinical checks as face-to-face consultations, including contraindication screening and drug interaction analysis.

Weight Loss Injections Stoke on Trent: Comparing Mounjaro vs Wegovy vs Saxenda

Choosing between weight loss injections Stoke on Trent patients can access depends on several clinical factors including BMI, diabetes status, injection frequency preference, and budget. Mounjaro (tirzepatide) offers the highest average weight reduction—up to 22.5% in clinical trials—making it ideal for patients with BMI ≥30 or ≥27 with comorbidities seeking maximum efficacy [1].

Wegovy (semaglutide) provides a middle ground with once-weekly dosing and proven 15% average weight loss, suitable for patients who prefer less frequent injections and demonstrated cardiovascular benefits in the SELECT trial [2]. Saxenda (liraglutide) requires daily injections but offers a lower starting price point at £124.99, making it accessible for patients beginning their weight loss journey or those with milder obesity.

All three treatments share common side effects—predominantly gastrointestinal symptoms like nausea, diarrhoea, and constipation—which typically diminish after the first 4-8 weeks as the body adapts [3]. Your prescriber will recommend the optimal choice based on your medical profile, previous treatment responses, and personal preferences regarding injection frequency and cost.

Clinical Eligibility for Weight Loss Injections in Stoke-on-Trent

To qualify for weight loss injections Stoke on Trent residents must meet specific MHRA-approved criteria. Generally, candidates have a BMI ≥30 kg/m² (obese) or BMI ≥27 kg/m² (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea [4].

Certain medical conditions contraindicate GLP-1 therapy. Patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease typically cannot use these treatments. Pregnant or breastfeeding women, and those planning pregnancy within the treatment timeframe, must avoid GLP-1 receptor agonists due to insufficient safety data.

Our prescribers conduct thorough medication interaction checks during assessment. Weight loss injections Stoke on Trent patients receive may require dose adjustments if taking insulin, sulfonylureas, or warfarin due to altered absorption rates and enhanced glycaemic control effects. Patients with diabetic retinopathy or gastroparesis require specialist evaluation before commencing treatment.

BMI Requirements and Health Assessments

The clinical threshold for prescribing weight loss injections Stoke on Trent follows NICE guidance: BMI ≥30 without comorbidities, or BMI ≥27 with documented weight-related health complications. Our assessment includes comprehensive review of previous weight loss attempts, dietary patterns, physical activity levels, and psychological readiness for long-term treatment adherence. Patients must demonstrate commitment to concurrent lifestyle modifications including caloric reduction and increased physical activity for optimal outcomes [4].

Weight Loss Injections Stoke on Trent: Expected Results and Timelines

Patients using weight loss injections Stoke on Trent typically observe initial results within 4-8 weeks, though peak efficacy develops over 6-12 months of continuous treatment. Mounjaro users in the SURPASS-2 trial achieved average weight loss of 7.6 kg at 12 weeks on the 5 mg dose, progressing to 11.2 kg by week 40 [1]. Wegovy demonstrated similar progressive reduction, with most weight loss occurring between weeks 20-60 [2].

Clinical trials establish realistic expectations: approximately 85% of Mounjaro users lose ≥5% body weight, while 50% achieve ≥15% reduction at maximum doses [1]. Wegovy shows 70% of patients reaching ≥10% weight loss at 68 weeks [2]. Saxenda produces more modest outcomes, with 63% losing ≥5% and 33% achieving ≥10% reduction [3].

Weight loss injections Stoke on Trent residents receive work best alongside comprehensive lifestyle changes. Our clinical team recommends reducing daily caloric intake by 500-750 kcal and incorporating 150+ minutes of moderate-intensity physical activity weekly. Patients who combine pharmacotherapy with structured diet and exercise programmes consistently outperform those relying on medication alone, achieving 20-25% greater total weight reduction in comparative studies.

Pricing and Ongoing Costs for Weight Loss Injections Stoke-on-Trent

Weight loss injections Stoke on Trent are priced transparently at Cured Pharmacy with no hidden consultation fees. Mounjaro starts from £124.99 per month, Wegovy from £124.99, and Saxenda from £124.99, with all prices displayed before you complete your clinical assessment. New patients receive £20 off their first order using code Weightlossnew, reducing initial costs to £124.99 for eligible treatments.

Treatment duration varies by individual response and goals. Most patients continue therapy for 12-18 months to achieve and consolidate target weight loss, followed by gradual dose reduction under prescriber supervision. Long-term maintenance may involve lower doses or intermittent treatment cycles. Our pricing structure remains consistent throughout your treatment journey—no price increases for established patients.

Compared to private clinic appointments in Staffordshire charging £124.99-300 per consultation plus separate medication costs, accessing weight loss injections Stoke on Trent through our online service delivers significant savings. We guarantee the lowest UK prices for genuine MHRA-licensed medicines, backed by our price-match commitment. All treatments include free delivery, ongoing prescriber support, and unlimited messaging access to our clinical team.

Insurance and NHS Availability in Stoke-on-Trent

NHS provision of weight loss injections Stoke on Trent remains severely restricted due to NICE guidance limiting prescribing to specialist weight management services for patients with BMI ≥35 and specific comorbidities. Waiting lists in Staffordshire CCG areas currently extend 12-18 months. Private prescription through Cured Pharmacy offers immediate access with clinical oversight matching NHS standards. Some private medical insurance policies cover GLP-1 treatments—check your policy terms or contact our team for documentation to support claims.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 29 September 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 29 September 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 29 September 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE guideline. [accessed 29 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 29 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 29 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 29 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.